Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danyang Sun

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Endocrinology|February 1, 2024
Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effectXue Li, Hongyuan Zheng, Chao Ma, et al.
Hellenic Journal of Nuclear Medicine|August 1, 2022
Predictive factors for the efficacy of <sup>131</sup>I therapy with formulated dosage calculation on Graves' diseaseHongbin Zheng, Danyang Sun, Qing Zhang, et al.
Brain Research|December 25, 2016
<sup>131</sup>I-labeled and DOX-loaded multifunctional nanoliposomes for radiotherapy and chemotherapy in brain gliomasJingmei Gao, Lei Fang, Danyang Sun, et al.
Journal of the American Chemical Society|January 12, 2018
A Stable Blue Photosensitizer for Color Palette of Dye-Sensitized Solar Cells Reaching 12.6% EfficiencyYameng Ren, Danyang Sun, Yiming Cao, et al.
Nuclear Medicine Communications|March 30, 2022
Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinomaRuixin Wu, Wei Liu, Ning Li, et al.
Annals of Nuclear Medicine|December 19, 2025
Clinical value of clinicopathological, ultrasonographic features and fibroblast activation protein in evaluating the radioiodine treatment efficacy in papillary thyroid carcinomaDongyue Chen, Li Zhu, Xue Li, et al.
RSC Advances|May 6, 2022
Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serumQi Chen, Danyang Sun, Hua Pei, et al.
Medicine|October 20, 2017
Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancerJunxun Ma, Sujie Zhang, Yi Hu, et al.
Journal of Gastrointestinal Oncology|January 18, 2021
A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancerDanyang Sun, Junxun Ma, Jinliang Wang, et al.
Endokrynologia Polska|September 5, 2022
Effects of high-activity radioactive iodine treatment on renal function in patients with differentiated thyroid carcinoma - retrospective studyLiang Yin, Weilong Li, Xiaolan Lv, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|February 1, 2024
Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effectXue Li, Hongyuan Zheng, Chao Ma, et al.
Hellenic Journal of Nuclear Medicine|August 1, 2022
Predictive factors for the efficacy of <sup>131</sup>I therapy with formulated dosage calculation on Graves' diseaseHongbin Zheng, Danyang Sun, Qing Zhang, et al.
Brain Research|December 25, 2016
<sup>131</sup>I-labeled and DOX-loaded multifunctional nanoliposomes for radiotherapy and chemotherapy in brain gliomasJingmei Gao, Lei Fang, Danyang Sun, et al.
Journal of the American Chemical Society|January 12, 2018
A Stable Blue Photosensitizer for Color Palette of Dye-Sensitized Solar Cells Reaching 12.6% EfficiencyYameng Ren, Danyang Sun, Yiming Cao, et al.
Nuclear Medicine Communications|March 30, 2022
Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinomaRuixin Wu, Wei Liu, Ning Li, et al.
Annals of Nuclear Medicine|December 19, 2025
Clinical value of clinicopathological, ultrasonographic features and fibroblast activation protein in evaluating the radioiodine treatment efficacy in papillary thyroid carcinomaDongyue Chen, Li Zhu, Xue Li, et al.
RSC Advances|May 6, 2022
Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serumQi Chen, Danyang Sun, Hua Pei, et al.
Medicine|October 20, 2017
Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancerJunxun Ma, Sujie Zhang, Yi Hu, et al.
Journal of Gastrointestinal Oncology|January 18, 2021
A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancerDanyang Sun, Junxun Ma, Jinliang Wang, et al.
Endokrynologia Polska|September 5, 2022
Effects of high-activity radioactive iodine treatment on renal function in patients with differentiated thyroid carcinoma - retrospective studyLiang Yin, Weilong Li, Xiaolan Lv, et al.
Pageof 5